19073384

Source:http://linkedlifedata.com/resource/pubmed/id/19073384

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0019682, umls-concept:C0019699, umls-concept:C0030705, umls-concept:C0042769, umls-concept:C0220847, umls-concept:C1066251
pubmed:issue	11
pubmed:dateCreated	2008-12-16
pubmed:abstractText	Chronic Hepatitis C Virus (HCV) infection is currently one of the most relevant coinfections in HIV positive patients. The influence of SEN Virus (SENV) on the outcome of HCV therapy in HIV/HCV coinfected patients who underwent combination therapy with pegylated interferon (PEG-IFN) and ribavirin is unclear.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9517857
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antiviral Agents, http://linkedlifedata.com/resource/pubmed/chemical/DNA, Viral, http://linkedlifedata.com/resource/pubmed/chemical/Interferon-alpha, http://linkedlifedata.com/resource/pubmed/chemical/Polyethylene Glycols, http://linkedlifedata.com/resource/pubmed/chemical/RNA, Viral, http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Ribavirin, http://linkedlifedata.com/resource/pubmed/chemical/interferon alfa-2a, http://linkedlifedata.com/resource/pubmed/chemical/peginterferon alfa-2a
pubmed:status	MEDLINE
pubmed:month	Nov
pubmed:issn	0949-2321
pubmed:author	pubmed-author:AdamsOO, pubmed-author:EmmelkampJJ, pubmed-author:HäussingerDD, pubmed-author:KupferBB, pubmed-author:OetteMM, pubmed-author:RockstrohJJ, pubmed-author:SagivEE, pubmed-author:VogelMM
pubmed:issnType	Print
pubmed:day	24
pubmed:volume	13
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	495-9
pubmed:dateRevised	2011-11-17
pubmed:meshHeading	pubmed-meshheading:19073384-Adult, pubmed-meshheading:19073384-Antiviral Agents, pubmed-meshheading:19073384-Comorbidity, pubmed-meshheading:19073384-DNA, Viral, pubmed-meshheading:19073384-DNA Virus Infections, pubmed-meshheading:19073384-Drug Resistance, Viral, pubmed-meshheading:19073384-Drug Therapy, Combination, pubmed-meshheading:19073384-Female, pubmed-meshheading:19073384-Genotype, pubmed-meshheading:19073384-HIV Infections, pubmed-meshheading:19073384-Hepacivirus, pubmed-meshheading:19073384-Hepatitis C, Chronic, pubmed-meshheading:19073384-Humans, pubmed-meshheading:19073384-Interferon-alpha, pubmed-meshheading:19073384-Male, pubmed-meshheading:19073384-Middle Aged, pubmed-meshheading:19073384-Polyethylene Glycols, pubmed-meshheading:19073384-Prevalence, pubmed-meshheading:19073384-RNA, Viral, pubmed-meshheading:19073384-Recombinant Proteins, pubmed-meshheading:19073384-Ribavirin, pubmed-meshheading:19073384-Torque teno virus, pubmed-meshheading:19073384-Virus Replication
pubmed:year	2008
pubmed:articleTitle	SEN Virus infection in HIV/HCV coinfected patients.
pubmed:affiliation	Klinik für Gastroenterologie, Hepatologie und Infektiologie, Universitätsklinik Düsseldorf, Moorenstr. 5, 40225 Düsseldorf, Germany. sagir@med.uni-duesseldorf.de
pubmed:publicationType	Journal Article